Dr. Benjamin Lowentritt serves as the Medical Director of the Comprehensive Prostate Cancer Care Program at Chesapeake Urology Associates. He also serves as Senior Vice-President of Practice Development and Director of Prostate Cancer Services for United Urology Group. Dr. Lowentritt is a member of the United Urology Group Executive Leadership Team.
In his role, Dr. Lowentritt has worked with member practices to build and optimize services for prostate cancer patients. This includes supporting physicians, staff, and operational teams treatment options are expanded. The goal is for each member group to have a comprehensive, state-of-the-art program that helps patients through a complex diagnosis. He is also directing Disease-State-Management programs for other conditions commonly treated by urologists.
Dr. Lowentritt received his Doctor of Medicine degree from Baylor College of Medicine, completed his medical residency at the University of Maryland School of Medicine and a fellowship in Robotic, Laparoscopic and Endoscopic Urology at Tulane University. His practice focuses on evaluation and management of prostate cancer through all stages of the disease. He has published extensively on prostate cancer treatments and has been an investigator on multiple clinical trials.
Dr. Lowentritt is a Past-President of MedChi, the Maryland State Medical Society and is a Board member of the Large Urology Group Practice Association (LUGPA), currently serving as Secretary. He is a Past-President of the Mid-Atlantic Section of the American Urological Association and of the Baltimore City Medical Society. He is the Medical Director for Urology for Cencora. He has been recognized as a Top Doctor in multiple publications.
Disclosure information not submitted.